60 Degrees Pharmaceuticals (SXTP) Income from Non-Controlling Interests (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) reported Income from Non-Controlling Interests of -$1,060 for Q2 2026, compared with -$1,204 a year earlier.
Powered by 
Analysis
60 Degrees Pharmaceuticals (SXTP) Income from Non-Controlling Interests (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, 60 Degrees Pharmaceuticals' Income from Non-Controlling Interests came in at -$3,212; for FY2025, it came in at -$3,167.
- By year, Income from Non-Controlling Interests came in at -$8,556 in FY2024, -$48,098 in FY2023 and $3,936 in FY2022.
- Five-year quarterly Income from Non-Controlling Interests spans a low of -$33,933 in Q4 2023 and a high of $5,390 in Q4 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$941.00 (Q1 2026), -$499.00 (Q4 2025) and -$712.00 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | 60 Degrees Pharmaceuticals | 3.70 Mn | 2.59 Mn | 56,798.00 | -1,060.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,060.00 |
| Mar 31, 2026 | -941.00 |
| Dec 31, 2025 | -499.00 |
| Sep 30, 2025 | -712.00 |
| Jun 30, 2025 | -1,204.00 |
| Mar 31, 2025 | -752.00 |
| Dec 31, 2024 | -3,887.00 |
| Sep 30, 2024 | -713.00 |
| Jun 30, 2024 | -1,471.00 |
| Mar 31, 2024 | -2,485.00 |
| Dec 31, 2023 | -33,933.00 |
| Sep 30, 2023 | -9,656.00 |
| Jun 30, 2023 | -7,036.00 |
| Mar 31, 2023 | 2,527.00 |
| Dec 31, 2022 | 5,390.00 |
| Sep 30, 2022 | -3,172.00 |
| Jun 30, 2022 | -3,117.00 |
API Access
60 Degrees Pharmaceuticals Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SXTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "SXTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=SXTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();